Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-27
DOI
10.3389/fphar.2020.00730
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer
- (2019) Magdalena Grill et al. Scientific Reports
- Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review
- (2019) Adérson Omar Mourão Cintra Damião et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications
- (2019) Agha Zeeshan Mirza et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Plant-Derived Alkaloids: The Promising Disease-Modifying Agents for Inflammatory Bowel Disease
- (2019) Jiao Peng et al. Frontiers in Pharmacology
- Flos Abelmoschus manihot extract attenuates DSS-induced colitis by regulating gut microbiota and Th17/Treg balance
- (2019) Wei Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Modern use of 5-aminosalicylic acid compounds for ulcerative colitis
- (2019) Catherine Le Berre et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease
- (2018) Amy Hemperly et al. CLINICAL PHARMACOKINETICS
- Mechanistic Understanding of Herbal Therapy in Inflammatory Bowel Disease
- (2018) Luqing Zhao et al. CURRENT PHARMACEUTICAL DESIGN
- The endogenous bioactive lipid prostaglandin D2-glycerol ester reduces murine colitis via DP1 and PPARγ receptors
- (2018) Mireille Alhouayek et al. FASEB JOURNAL
- Tropisetron attenuates lipopolysaccharide induced neuroinflammation by inhibiting NF-κB and SP/NK1R signaling pathway
- (2018) Yan YU et al. JOURNAL OF NEUROIMMUNOLOGY
- Magnolol treatment attenuates dextran sulphate sodium-induced murine experimental colitis by regulating inflammation and mucosal damage
- (2018) Peng Shen et al. LIFE SCIENCES
- 5-aminosalicylic acid improves lipid profile in mice fed a high-fat cholesterol diet through its dual effects on intestinal PPARγ and PPARα
- (2018) Zheng Wang et al. PLoS One
- Portulaca Extract Attenuates Development of Dextran Sulfate Sodium Induced Colitis in Mice through Activation of PPARγ
- (2018) Rui Kong et al. PPAR Research
- Chemical Crosslinking Mass Spectrometry Reveals the Conformational Landscape of the Activation Helix of PPARγ; a Model for Ligand-Dependent Antagonism
- (2018) Jie Zheng et al. STRUCTURE
- The role of obesity in inflammatory bowel disease
- (2018) Roxane Kreuter et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- A partial agonist for retinoid X receptor mitigates experimental colitis
- (2018) Masayoshi Onuki et al. INTERNATIONAL IMMUNOLOGY
- A structural mechanism for directing corepressor-selective inverse agonism of PPARγ
- (2018) Richard Brust et al. Nature Communications
- Dietary n-3 polyunsaturated fatty acids ameliorate Crohn's disease in rats by modulating the expression of PPAR-γ/NFAT
- (2017) Jiayin Yao et al. Molecular Medicine Reports
- Environmental triggers in IBD: a review of progress and evidence
- (2017) Ashwin N. Ananthakrishnan et al. Nature Reviews Gastroenterology & Hepatology
- Role of glycogen synthase kinase-3β and PPAR-γ on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis
- (2017) Jacopo Di Gregorio et al. PLoS One
- rSj16 Protects against DSS-Induced Colitis by Inhibiting the PPAR-α Signaling Pathway
- (2017) Lifu Wang et al. Theranostics
- New Frontiers in Genetics, Gut Microbiota, and Immunity: A Rosetta Stone for the Pathogenesis of Inflammatory Bowel Disease
- (2017) Mingxia Zhou et al. Biomed Research International
- Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges
- (2017) Marcel Vetter et al. Therapeutic Advances in Gastroenterology
- Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease
- (2017) Ming Zhang et al. Frontiers in Immunology
- Oleoylethanolamide prevents neuroimmune HMGB1/TLR4/NF-kB danger signaling in rat frontal cortex and depressive-like behavior induced by ethanol binge administration
- (2016) María Antón et al. ADDICTION BIOLOGY
- Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation
- (2016) Daniela Impellizzeri et al. BIOCHEMICAL PHARMACOLOGY
- Anti-inflammatory effects of an oxylipin-containing lyophilised biomass from a microalga in a murine recurrent colitis model
- (2016) Javier Ávila-Román et al. BRITISH JOURNAL OF NUTRITION
- Fatty acids, eicosanoids and PPAR gamma
- (2016) Rachel Marion-Letellier et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Involvement of PPARγ in the protective action of tropisetron in an experimental model of ulcerative colitis
- (2016) Reza Rahimian et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis
- (2016) Silvia Speca et al. INFLAMMATORY BOWEL DISEASES
- The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease
- (2016) C. Hasenoehrl et al. NEUROGASTROENTEROLOGY AND MOTILITY
- High-fat diet modifies the PPAR-γ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine
- (2016) Julie Tomas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Voluntary exercise protects against ulcerative colitis by up-regulating glucocorticoid-mediated PPAR-γactivity in the colon in mice
- (2015) W.-X. Liu et al. Acta Physiologica
- Voluntary exercise prevents colonic inflammation in high-fat diet-induced obese mice by up-regulating PPAR-γ activity
- (2015) Wei-Xin Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Stimulation of nuclear receptor peroxisome proliferator-activated receptor-γ limits NF-κB-dependent inflammation in mouse cystic fibrosis biliary epithelium
- (2015) Roberto Scirpo et al. HEPATOLOGY
- A Novel Peroxisome Proliferator-activated Receptor (PPAR)γ Agonist 2-Hydroxyethyl 5-chloro-4,5-didehydrojasmonate Exerts Anti-Inflammatory Effects in Colitis
- (2015) Jieun Choo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epidemiology and risk factors for IBD
- (2015) Ashwin N. Ananthakrishnan Nature Reviews Gastroenterology & Hepatology
- Dietary n-3 PUFA Protects Mice from Con A Induced Liver Injury by Modulating Regulatory T Cells and PPAR-γ Expression
- (2015) Min Lian et al. PLoS One
- Establishing the Role of PPARβ/δ in Carcinogenesis
- (2015) Jeffrey M. Peters et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent
- (2014) Francesca Borrelli et al. BRITISH JOURNAL OF PHARMACOLOGY
- Peroxisome Proliferator-Activated Receptors Family Is Involved in the Response to Treatment and Mild Clinical Course in Patients with Ulcerative Colitis
- (2014) J. K. Yamamoto-Furusho et al. DISEASE MARKERS
- Intestinal steroidogenesis controls PPARγ expression in the colon and is impaired during ulcerative colitis
- (2014) Guillaume Bouguen et al. GUT
- Chitinase-like proteins promote IL-17-mediated neutrophilia in a tradeoff between nematode killing and host damage
- (2014) Tara E Sutherland et al. NATURE IMMUNOLOGY
- Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
- (2014) Bogna Grygiel-Górniak Nutrition Journal
- PPAR-Gamma in Ulcerative Colitis: A Novel Target for Intervention
- (2013) Benjamin Bertin et al. CURRENT DRUG TARGETS
- Peroxisome proliferator-activated receptor δ
- (2013) Lazar A. Bojic et al. CURRENT OPINION IN LIPIDOLOGY
- Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease
- (2013) Ashwin N Ananthakrishnan et al. GUT
- Polyunsaturated Fatty Acids in Inflammatory Bowel Diseases
- (2013) Rachel Marion-Letellier et al. INFLAMMATORY BOWEL DISEASES
- Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
- (2013) Irene Paterniti et al. Journal of Neuroinflammation
- PPARγ signaling and metabolism: the good, the bad and the future
- (2013) Maryam Ahmadian et al. NATURE MEDICINE
- Crohn's disease
- (2012) Daniel C Baumgart et al. LANCET
- Ulcerative Colitis Impairs the Acylethanolamide-Based Anti-Inflammatory System Reversal by 5-Aminosalicylic Acid and Glucocorticoids
- (2012) Juan Suárez et al. PLoS One
- Infliximab modifies mesenteric adipose tissue alterations and intestinal inflammation in rats with TNBS-induced colitis
- (2012) Thayane Rodrigues Leite Clemente et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
- (2011) Nicholas J Talley et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of Immunosuppressive Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- (2011) Khurram J Khan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- (2011) Khurram J Khan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Epidemiology and Natural History of Inflammatory Bowel Diseases
- (2011) Jacques Cosnes et al. GASTROENTEROLOGY
- Antibodies Against Tumor Necrosis Factor (TNF) Induce T-Cell Apoptosis in Patients With Inflammatory Bowel Diseases via TNF Receptor 2 and Intestinal CD14+ Macrophages
- (2011) Raja Atreya et al. GASTROENTEROLOGY
- Role of genetic and environmental factors in British twins with inflammatory bowel disease
- (2011) Siew C. Ng et al. INFLAMMATORY BOWEL DISEASES
- Exercise-associated generation of PPARγ ligands activates PPARγ signaling events and upregulates genes related to lipid metabolism
- (2011) A. W. Thomas et al. JOURNAL OF APPLIED PHYSIOLOGY
- The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease
- (2011) A Di Sabatino et al. Mucosal Immunology
- Ulcerative Colitis
- (2011) Silvio Danese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease
- (2011) Chadwick Williams et al. Therapeutic Advances in Gastroenterology
- Fibrates, Glitazones, and Peroxisome Proliferator–Activated Receptors
- (2010) Fanny Lalloyer et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Molecular basis for gene-specific transactivation by nuclear receptors
- (2010) Mads M. Aagaard et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Peroxisome proliferator-activated receptor-gamma (PPAR-γ) expression is downregulated in patients with active ulcerative colitis
- (2010) Jesús K. Yamamoto-Furusho et al. INFLAMMATORY BOWEL DISEASES
- PPARα contributes to colonic protection in mice with DSS-induced colitis
- (2010) Yasu-Taka Azuma et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Immunoregulatory mechanisms of macrophage PPAR-γ in mice with experimental inflammatory bowel disease
- (2010) R Hontecillas et al. Mucosal Immunology
- Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon
- (2010) L. Peyrin-Biroulet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coactivators in PPAR-Regulated Gene Expression
- (2010) Navin Viswakarma et al. PPAR Research
- PPAR-αContributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in Mice
- (2010) Emanuela Esposito et al. PPAR Research
- Peroxisome Proliferator-Activated Receptor γ and Cardiovascular Diseases
- (2009) Hiroyuki Takano et al. CIRCULATION JOURNAL
- Effects of verbascoside biotechnologically produced by Syringa vulgaris plant cell cultures in a rodent model of colitis
- (2009) Emanuela Mazzon et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Inflammatory Bowel Disease
- (2009) Clara Abraham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation
- (2009) C. Solorzano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-α MODULATES THE ANTI-INFLAMMATORY EFFECT OF GLUCOCORTICOIDS IN A MODEL OF INFLAMMATORY BOWEL DISEASE IN MICE
- (2009) Luisa Riccardi et al. SHOCK
- Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors
- (2008) Martin A. Storr et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- PPAR-γ agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-β
- (2008) Toru Kawai et al. LABORATORY INVESTIGATION
- The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB1, TRPV1 and PPARγ receptors and neurotrophic factors
- (2008) Barbara Costa et al. PAIN
- Enterococcus faecalis from newborn babies regulate endogenous PPAR activity and IL-10 levels in colonic epithelial cells
- (2008) A. Are et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evidence for the involvement of infectious agents in the pathogenesis of Crohn’s disease
- (2008) Gert De Hertogh WORLD JOURNAL OF GASTROENTEROLOGY
- Is There a Role for Fibrates in the Management of Dyslipidemia in the Metabolic Syndrome?
- (2007) Philip J. Barter et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- PPARα agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages
- (2007) E-L Paukkeri et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cellular and molecular mechanisms of fibrosis
- (2007) TA Wynn JOURNAL OF PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now